In 2015, Gaurav Shah co-founded Rocket Pharmaceuticals to cure devastating childhood diseases. The company is now one of the key leaders in gene therapy as a result of their patient-first approach. When they started working with First Republic, Rocket Pharmaceuticals was pleased to discover that the Bank’s client service was of a similar nature — people-centric, authentic and responsive. With First Republic focused on serving their financial needs, Rocket Pharmaceuticals can focus on breakthroughs in biotech, rather than balance sheets. As Gaurav and his team continue to reimagine what’s possible, First Republic will be by their side every step of the way.